Incidence and risk factors for agranulocytosis in Latin American countries - The Latin Study: A multicenter study

European Journal of Clinical Pharmacology

Volumn 64, Issue 9, 2008, Pages 921-929

  Hamerschlak, Nelson ^a   Maluf, Eliane ^b   Biasi Cavalcanti, Alexandre ^a   Avezum Jr , Álvaro ^a   Eluf Neto, José ^c   Passeto Falcão, Roberto ^c   Lorand Metze, Irene Gyongyvér Heidemarie ^d   Goldenberg, Daniel ^e   Leite Santana, Cézar ^f   De Oliveira Werneck Rodrigues, Daniela ^g   Nascimento Da Motta Passos, Leny ^h   Oliveira De Miranda Coelho, Erika ⁱ   Tostes Pintão, Maria Carolina ^c   Moraes De Souza, Hélio ^j   Borbolla, José Rafael ^k   Pasquini, Ricardo ^b  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF CAMPINAS   (Brazil)

^e Obra Social Bancaria Argentina ^*  (Argentina)

^f Instituto de Hemoterapia de Goiânia IHG   (Brazil)

^g University of Juiz de Fora   (Brazil)

^h Fundacao de Hematologia e Hemoterapia do Amazonas   (Brazil)

ⁱ Fundacao Hemope   (Brazil)

^j Hemocentro Regional de Uberaba   (Brazil)

^k Hospital San Jose Tec de Monterrey   (Mexico)

more..

Author keywords

Agranulocytosis; Dipyrone; Incidence; Methimazole; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; CAFFEINE; CALCIUM CARBONATE; CAPTOPRIL; DIAZEPAM; DICLOFENAC; DIPYRONE; ESTRADIOL; FERROUS SULFATE; FUROSEMIDE; GINKGO BILOBA EXTRACT; HYDROCHLOROTHIAZIDE; IBUPROFEN; LORATADINE; MAGNESIUM CHLORIDE; MEDROXYPROGESTERONE; MULTIVITAMIN; NIFEDIPINE; NIMESULIDE; NORETHISTERONE; NORFLOXACIN; OMEPRAZOLE; PARACETAMOL; PHENYTOIN; PROPRANOLOL; PSEUDOEPHEDRINE; SIMVASTATIN; THIAMAZOLE; VALDECOXIB;

ADOLESCENT; ADULT; AGED; AGRANULOCYTOSIS; ARGENTINA; ARTICLE; BRAZIL; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG USE; FEMALE; GROUPS BY AGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEXICO; MULTICENTER STUDY; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SOUTH AND CENTRAL AMERICA; STATISTICAL ANALYSIS;

AGED; AGRANULOCYTOSIS; ANTITHYROID AGENTS; CASE-CONTROL STUDIES; CHILD; DATA COLLECTION; FEMALE; HUMANS; INCIDENCE; INTERVIEWS AS TOPIC; LATIN AMERICA; MALE; METHIMAZOLE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; QUESTIONNAIRES; RISK FACTORS;

EID: 50849119085     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-008-0513-7     Document Type: Article

References (25)

1. L Ibáñez X Vidal E Ballarín JR Laporte 2005 Population-based drug-induced agranulocytosis Arch Intern Med 165 8 869 874
2. NS Young 1994 Agranulocytosis JAMA 271 12 935 938
3. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study. JAMA 256(13):1749-1757
4. N Hamerschlak AB Cavalcanti 2005 Neutropenia, agranulocytosis and dipyrone Sao Paulo Med J 123 5 247 249
5. DW Kaufman JP Kelly JM Jurgelon 1996 Drugs in the aetiology of agranulocytosis and aplastic anaemia Eur J Haematol Suppl 60 23 30
6. Kaufman DW, Kelly JP, Levy M, Shapiro S (1991) The drug etiology of agranulocytosis and aplastic anemia: the international agranulocytosis and aplastic anemia study. New York, Oxford University Press
7. F Andersohn C Konzen E Garbe 2007 Systematic review: agranulocytosis induced by nonchemotherapy drugs Ann Intern Med 146 9 657 665
8. L Ibáñez X Vidal E Ballarín JR Laporte 2005 Agranulocytosis associated with dipyrone (metamizol) Eur J Clin Pharmacol 60 11 821 829
9. S Shapiro S Issaragrisil DW Kaufman 1999 Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group Am J Trop Med Hyg 60 4 573 577
10. N Hamerschlak MP Montezuma N Bacal 1993 Retrospective prevalence and incidence of drug-induced agranulocytosis in the city of São Paulo-Brazil Rev Paul Med 111 1 294 298
11. N Hamerschlak E Maluf R Pasquini 2005 Incidence of aplastic anemia and agranulocytosis in Latin America-the LATIN study Sao Paulo Med J 123 3 101 104
12. Hennekens CH, Buring JE (1987) Measures of disease frequency. In: Hennekens CH, Buring E (eds) Epidemiology in medicine. Lippincott, Williams & Wilkins, Philadelphia
13. LK Hine BB Gerstman RP Wise Y Tsong 1990 Mortality resulting from blood dyscrasias in the United States, 1984 Am J Med 88 2 151 153
14. LE Böttiger AK Furhoff L Holmberg 1979 Drug-induced blood dyscrasias. A ten-year material from the Swedish Adverse Drug Reaction Committee Acta Med Scand 205 6 457 461
15. P Arneborn J Palmblad 1979 Drug-induced neutropenias in the Stockholm region 1976-1977 Acta Med Scand 206 4 241 243
16. P Arneborn J Palmblad 1982 Drug-induced neutropenia-a survey for Stockholm 1973-1978 Acta Med Scand 212 5 289 292
17. N Tavassoli E Duchayne B Sadaba 2007 Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals Eur J Clin Pharmacol 63 3 221 228
18. E Andrès J Zimmer S Affenberger 2006 Idiosyncratic drug-induced agranulocytosis: Update of an old disorder Eur J Intern Med 17 8 529 535
19. IM Benseñor 2005 Dipyrone and blood dyscrasia revisited: "non-evidence based medicine" Sao Paulo Med J 123 3 99 100
20. S Garcia M Canionero G Lopes 2006 Dipyrone-induced granulocytopenia: a case for awareness Pharmacotherapy 26 3 440 442
21. K Hedenmalm O Spigset 2002 Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole) Eur J Clin Pharmacol 58 4 265 274
22. Carvalho-Silva DR, Santos FR, Rocha J, Pena SD (2001) The phylogeography of Brazilian Y-chromosome lineages. Am J Hum Genet 68(1):281-286
23. M Dettling I Cascorbi C Opgen-Rhein R Schaub 2007 Clozapine-induced agranulocytosis in schizophrenic Caucasians: confirming clues for associations with human leukocyte class I and II antigens Pharmacogenomics J 7 5 325 332
24. Y Güzelcan WF Scholte 2006 Door clozapine geïnduceerde agranulocytose: genetische en immunologische verklaringen. [Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model] Tijdschr Psychiatr 48 4 295 302
25. World Health Organization (2006) WHO Statistical Information System (WHOSIS). Core Health Indicators. World Health Organization. http://www.who.int/whosis/database/core/core_select.cfm. Accessed 15 Feb 2007